Status:
UNKNOWN
Point-of-Care Multiplex for Adult Patients With Severe Community-acquired Pneumonia
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Community-acquired Pneumonia
Critical Illness
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Clinical Impact on Point-of-Care Multiplex PCR Testing for Critically Ill Adult Patients With Community-acquired Pneumonia - A cluster randomization study in ICU units within one medical center.
Detailed Description
Point-of-Care Multiplex PCR Testing could narrow down the pathogens causing severe community-acquired pneumonia(CAP). Our hypothesis is that the result of Point-of-Care Multiplex PCR Testing could hel...
Eligibility Criteria
Inclusion
- Adult patients (age \>20 y/o)
- ICU admission for acute respiratory failure due to community-acquired pneumonia by clinical diagnosis
- Treatment with endotracheal Intubation
Exclusion
- Aspiration pneumonia (including witnessed aspiration and chronic bedridden status)
- Nosocomial infection
Key Trial Info
Start Date :
May 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04835818
Start Date
May 2 2019
End Date
May 1 2022
Last Update
October 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan